N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine
C26H22FN5O — CID 127024373
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine
N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine (PubChem CID 127024373) has the molecular formula C26H22FN5O and a molecular weight of 439.49 g/mol. Its IUPAC name is N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine.
Molecular Properties
| Compound Name | N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine |
|---|---|
| PubChem CID | 127024373 |
| Molecular Formula | C26H22FN5O |
| Molecular Weight | 439.49 g/mol |
| Exact Mass | 439.18 |
| IUPAC Name | N-[(1S)-1-[5-(5-fluoro-3-pyridinyl)-3-pyridinyl]ethyl]-2-methyl-6-(3-methyl-1-benzofuran-5-yl)pyrimidin-4-amine |
| SMILES | Cc1nc(N[C@@H](C)c2cncc(-c3cncc(F)c3)c2)cc(-c2ccc3occ(C)c3c2)n1 |
| InChI | InChI=1S/C26H22FN5O/c1-15-14-33-25-5-4-18(8-23(15)25)24-9-26(32-17(3)31-24)30-16(2)19-6-20(11-28-10-19)21-7-22(27)13-29-12-21/h4-14,16H,1-3H3,(H,30,31,32)/t16-/m0/s1 |
| InChIKey | VZFSQJYQFOFZQZ-INIZCTEOSA-N |
| XLogP | 6.28 |
| TPSA | 76.73 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.49 |
| LogP ≤ 5 | 6.28 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127024373 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.